Impact of Sleep Workshops in College Students
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02665247 |
Recruitment Status :
Completed
First Posted : January 27, 2016
Last Update Posted : July 7, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Sleep Insomnia Sleep Deprivation | Behavioral: C-SIP Other: Dream discussion | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 180 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Impact of Sleep Workshops in College Students |
Actual Study Start Date : | October 24, 2016 |
Actual Primary Completion Date : | November 24, 2019 |
Actual Study Completion Date : | November 24, 2019 |
Arm | Intervention/treatment |
---|---|
Experimental: C-SIP
Participants assigned to the C-SIP group will attend sessions where information about sleep is presented. In session I, information about sleep and the effects of lack of sleep will be presented. Participants will also be presented with advice and tips on how to improve sleep. Session II will focus on assisting participants overcome any barriers they faced in applying the advice they received in session I; participants will also receive additional information on sleep and sleep-related techniques.
|
Behavioral: C-SIP
In session I, information about sleep and the effects of lack of sleep will be presented. Participants will also be presented with advice and tips on how to improve sleep. Session II will focus on assisting participants overcome any barriers they faced in applying the advice they received in session I; participants will also receive additional information on sleep and sleep-related techniques. |
Control Session
Participants assigned to the control group will attend sessions in which information on sleep is presented in the form of dream discussions.
|
Other: Dream discussion
Participants assigned to the control group will attend sessions in which information on sleep is presented in the form of dream discussions. |
- Change in Center for Epidemiologic Studies Depression Scale (CESD) score from baseline [ Time Frame: 13 weeks ]
- Change in Epworth Sleepiness Scale (ESS) score from baseline [ Time Frame: 13 weeks ]
- Change in Fatigue Severity Scale (FSS) score from baseline [ Time Frame: 13 weeks ]
- Change in Health Behaviors Survey (HBS) score from baseline [ Time Frame: 13 weeks ]
- Change in Morningness-Eveningness Questionnaire (MEQ-SA) from baseline [ Time Frame: 13 weeks ]
- Change in Perceived Stress Scale (PSS) score from baseline [ Time Frame: 13 weeks ]
- Change in Pittsburgh Sleep Quality Index (PSQI) score from baseline [ Time Frame: 13 weeks ]
- Change in Sleep Hygiene Index (SHI) score from baseline [ Time Frame: 13 weeks ]
- Change in State Trait Anxiety Inventory for Adults (Y-6 item) (STAI-Y6) score from baseline [ Time Frame: 13 weeks ]
- Change in Sleep Student Behavior Survey (SSBS) score from baseline [ Time Frame: 13 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 25 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Currently enrolled in classes at the NYU Washington Square campus
Exclusion Criteria:
- Students previously enrolled in the "While You Were Sleeping" course at NYU

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02665247
United States, New York | |
NYU School of Medicine | |
New York, New York, United States, 10016 |
Principal Investigator: | Jess Shatkin | NYU Langone Medical Center |
Responsible Party: | NYU Langone Health |
ClinicalTrials.gov Identifier: | NCT02665247 |
Other Study ID Numbers: |
15-00847 |
First Posted: | January 27, 2016 Key Record Dates |
Last Update Posted: | July 7, 2022 |
Last Verified: | July 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Sleep Deprivation Dyssomnias Sleep Wake Disorders |
Nervous System Diseases Neurologic Manifestations Mental Disorders |